Nanosonics Limited (OTCMKTS:NNCSF – Get Free Report) shares traded down 7.4% on Tuesday . The company traded as low as $2.1850 and last traded at $2.1850. 2,000 shares were traded during mid-day trading, an increase of 56% from the average session volume of 1,285 shares. The stock had previously closed at $2.36.
Nanosonics Stock Performance
The company has a 50-day simple moving average of $2.46 and a 200-day simple moving average of $2.49.
Nanosonics Company Profile
Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.
The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.
Further Reading
- Five stocks we like better than Nanosonics
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Nanosonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosonics and related companies with MarketBeat.com's FREE daily email newsletter.
